Discover how first-mover advantage shapes success for generic drug makers. Learn why timing matters, how the Hatch-Waxman Act works, and what strategies top companies use to stay ahead.
Drug patents last 20 years from filing, but most drugs only have 7-12 years of real market exclusivity due to long approval times. Patent extensions, regulatory exclusivity, and litigation can delay generics for years.